BCHE and early-onset autosomal dominant Alzheimer disease: The current study suggested polyacetylene glycosides as promising leads for the dual inhibition of 5-LOX and BchE enzymes, which could be applied for the prevention and treatment of neuroinflammatory disorders, such as Alzheimer’s disease.